Literature DB >> 8090727

An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

A J Bett1, W Haddara, L Prevec, F L Graham.   

Abstract

Human adenoviruses (Ads) are attracting considerable attention because of their potential utility for gene transfer and gene therapy, for development of live viral vectored vaccines, and for protein expression in mammalian cells. Engineering Ad vectors for these applications requires a variety of reagents in the form of Ads and bacterial plasmids containing viral DNA sequences and requires different strategies for construction of vectors for different purposes. To simplify Ad vector construction and develop a procedure with maximum flexibility, efficiency, and cloning capacity, we have developed a vector system based on use of Ad5 DNA sequences cloned in bacterial plasmids. Expanded deletions in early region 1 (3180 bp) and early region 3 (2690 or 3132 bp) can be combined in a single vector that should have a capacity for inserts of up to 8.3 kb, enough to accommodate the majority of cDNAs encoding proteins with regulatory elements. Genes can be inserted into either early region 1 or 3 or both and mutations or deletions can be readily introduced elsewhere in the viral genome. To illustrate the flexibility of the system, we have introduced a wild-type early region 3 into the vectors, and to illustrate the high capacity for inserts, we have isolated a vector with two genes totaling 7.8 kb.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090727      PMCID: PMC44694          DOI: 10.1073/pnas.91.19.8802

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Genome structure of incomplete particles of adenovirus.

Authors:  E Daniell
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

2.  Viral DNA sequences from incomplete particles of human adenovirus type 7.

Authors:  C Tibbetts
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

3.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

4.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  In vivo consequences of plasmid topology.

Authors:  D M Lilley
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

7.  Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome.

Authors:  M L Hammarskjöld; G Winberg
Journal:  Cell       Date:  1980-07       Impact factor: 41.582

8.  Covalently closed circles of adenovirus 5 DNA.

Authors:  M Ruben; S Bacchetti; F Graham
Journal:  Nature       Date:  1983-01-13       Impact factor: 49.962

9.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

10.  Tn5 mutagenesis of the transforming genes of human adenovirus type 5.

Authors:  R D McKinnon; S Bacchetti; F L Graham
Journal:  Gene       Date:  1982 Jul-Aug       Impact factor: 3.688

View more
  188 in total

1.  Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.

Authors:  D Hartigan-O'Connor; A Amalfitano; J S Chamberlain
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency.

Authors:  B T Tan; L Wu; A J Berk
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival.

Authors:  Y Fujio; K Guo; T Mano; Y Mitsuuchi; J R Testa; K Walsh
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

4.  Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression.

Authors:  L He; J Liu; I Collins; S Sanford; B O'Connell; C J Benham; D Levens
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 5.  Recent advances in molecular biological techniques and their relevance to pulmonary research.

Authors:  B W Robinson; D J Erle; D A Jones; S Shapiro; W J Metzger; S M Albelda; W C Parks; A Boylan
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

6.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.

Authors:  M I Miyamoto; F del Monte; U Schmidt; T S DiSalvo; Z B Kang; T Matsui; J L Guerrero; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

7.  Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis.

Authors:  J G Toma; H El-Bizri; F Barnabe-Heider; R Aloyz; F D Miller
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

8.  Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.

Authors:  M Hillgenberg; H Tönnies; M Strauss
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Construction of adenoviral vectors.

Authors:  A R Davis; N A Wivel; J L Palladino; L Tao; J M Wilson
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

10.  Reconstitution of cyclin D1-associated kinase activity drives terminally differentiated cells into the cell cycle.

Authors:  L Latella; A Sacco; D Pajalunga; M Tiainen; D Macera; M D'Angelo; A Felici; A Sacchi; M Crescenzi
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.